bioMerieux SAEURONEXT: BIM

WHO Grants Emergency Use Listing for BIOFIRE Global Fever Special Pathogens Panel, Expanding Access to Differential Diagnostics for the Ebola Response

· Issued by bioMerieux SA

Summary by 6ix AI

The World Health Organization (WHO) has granted Emergency Use Listing to BioMerieux's BIOFIRE Global Fever Special Pathogens Panel, a diagnostic panel.

Key details

  • BioMerieux says the listing expands access to differential diagnostics, meaning tests that help tell apart possible causes of an illness, for the Ebola response.

6ix AI wrote this summary from the release below and checked it against the release.

On 6ix: 6ix.com/news/biomerieux-who-grants-emergency-use-listing-for-biofire-global-fever-special-pathogens-panel-expanding-access-to-differential-diagnostics-for-the-ebola-response

Watch bioMerieux's latest callBiomerieux (Euronext:BIM) Q2 2026 Earnings Call · Replay · Jul 28Read the transcript of Biomerieux (Euronext:BIM) Q2 2026 Earnings Call

19 Oct 2026 18:00 CEST

Subscribe
Issuer

BIOMERIEUX

See attachment(s) / Voir document(s) joint(s) / Zie bijlage / Ver documento(s) em anexo

16165_1441049_20261019_Global_Fever_Special_Pathogens_Panel_Emergency_Listing_WHO_PR.pdf

Source

BIOMERIEUX

Provider

Les Echos

Company Name

BIOMERIEUX

ISIN

FR0013280286

Symbol

BIM

Market

Euronext

Company press releases subscription ×
To subscribe to Press releases from this issuer, visit the Subscription to Company news section in your account section or create an account.
Cancel

bioMerieux SA on 6ix

Earlier from bioMerieux

All bioMerieux news releases